Robert Ritch has always respected and studied Warren Buffets techniques and planned to implement them in his version and therefore has purchased the controlling block of preferred shares of Manzo Pharmaceuticals, Inc. (OTC: MNZO) and taken the position of President with the firm. Robert Ritch stated the first steps would be to bring the companies filing up to date and then acquire in whole or in part operating companies. There will also be a name change, but the new name has not been finalized or filed for at this time. The currently planned verticals are energy, technology, real estate and financial services.